Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

HTGC | Hercules Capital, Inc.

Index- P/E7.42 EPS (ttm)2.22 Insider Own1.00% Shs Outstand152.08M Perf Week-0.27%
Market Cap2.47B Forward P/E8.47 EPS next Y1.94 Insider Trans0.48% Shs Float149.32M Perf Month0.52%
Income302.00M PEG1.48 EPS next Q0.49 Inst Own25.70% Short Float / Ratio4.63% / 7.06 Perf Quarter17.17%
Sales405.70M P/S6.09 EPS this Y-47.00% Inst Trans1.08% Short Interest6.92M Perf Half Y36.56%
Book/sh11.21 P/B1.47 EPS next Y-2.46% ROA9.70% Target Price17.69 Perf Year26.52%
Cash/sh0.41 P/C40.02 EPS next 5Y5.00% ROE20.70% 52W Range10.82 - 17.97 Perf YTD26.46%
Dividend1.60 P/FCF- EPS past 5Y-3.60% ROI6.20% 52W High-8.41% Beta1.37
Dividend %9.72% Quick Ratio- Sales past 5Y11.00% Gross Margin81.90% 52W Low52.03% ATR0.29
Employees100 Current Ratio- Sales Q/Q61.20% Oper. Margin62.40% RSI (14)52.54 Volatility1.42% 1.58%
OptionableYes Debt/Eq1.00 EPS Q/Q853.80% Profit Margin74.40% Rel Volume0.57 Prev Close16.24
ShortableYes LT Debt/Eq1.00 EarningsAug 03 AMC Payout66.40% Avg Volume979.81K Price16.45
Recom2.00 SMA201.04% SMA50-0.23% SMA20014.31% Volume391,792 Change1.32%
Date Action Analyst Rating Change Price Target Change
Aug-30-23Upgrade Compass Point Neutral → Buy $17.50
Aug-04-23Upgrade Keefe Bruyette Underperform → Mkt Perform $13.50 → $17
Apr-06-23Upgrade Piper Sandler Neutral → Overweight $16
Mar-13-23Downgrade Keefe Bruyette Mkt Perform → Underperform $14.50 → $10.50
Jul-29-22Downgrade Oppenheimer Outperform → Perform
Apr-22-22Downgrade Keefe Bruyette Outperform → Mkt Perform $18
Apr-04-22Downgrade Piper Sandler Overweight → Neutral $19
Feb-08-22Downgrade Compass Point Buy → Neutral $18
Apr-28-21Initiated Oppenheimer Outperform $17.50
Mar-25-21Initiated RBC Capital Mkts Outperform $17
Sep-15-23 06:15PM
Sep-08-23 06:15PM
Aug-31-23 06:00AM
Aug-30-23 09:49AM
Aug-28-23 08:46AM
08:42PM Loading…
Aug-07-23 08:42PM
Aug-04-23 03:49PM
Aug-03-23 10:00PM
07:44AM Loading…
Aug-02-23 07:44AM
Aug-01-23 08:02AM
Jul-31-23 06:52AM
Jul-26-23 06:15PM
Jul-24-23 09:00AM
Jul-13-23 08:49AM
Jul-12-23 08:27AM
Jul-10-23 11:22AM
Jul-07-23 10:28AM
07:00AM Loading…
Jul-05-23 07:00AM
Jul-03-23 08:42AM
Jun-09-23 06:15PM
Jun-02-23 06:15PM
May-24-23 09:05AM
May-22-23 09:30AM
May-15-23 11:00AM
May-11-23 06:00AM
May-09-23 09:30AM
May-05-23 12:31PM
May-04-23 07:25PM
May-02-23 06:00AM
Apr-28-23 10:00AM
Apr-27-23 10:02AM
Apr-26-23 09:55AM
Apr-25-23 06:15PM
Apr-20-23 06:00AM
Apr-18-23 03:10PM
Apr-14-23 09:35AM
Apr-12-23 08:01AM
Apr-10-23 09:55AM
Apr-06-23 06:15PM
Apr-04-23 06:00AM
Mar-31-23 06:00PM
Mar-30-23 08:33AM
Mar-29-23 06:15PM
Mar-27-23 06:00AM
Mar-23-23 06:15PM
Mar-22-23 06:00AM
Mar-20-23 10:12AM
Mar-16-23 09:35AM
Mar-15-23 04:13AM
Mar-14-23 10:02AM
Mar-13-23 06:31AM
Mar-08-23 08:49AM
Mar-07-23 09:35AM
Mar-03-23 08:32AM
Feb-24-23 06:00AM
Feb-23-23 08:18AM
Feb-21-23 09:55AM
Feb-20-23 07:40AM
Feb-17-23 06:44AM
Feb-16-23 04:10PM
Feb-14-23 06:03AM
Feb-09-23 10:00AM
Feb-08-23 07:15AM
Feb-07-23 06:00PM
Feb-06-23 06:15PM
Feb-02-23 04:01PM
Jan-31-23 06:00PM
Jan-25-23 06:00PM
Jan-20-23 06:15PM
Jan-13-23 06:00PM
Jan-09-23 06:15PM
Jan-03-23 07:30PM
Dec-27-22 07:55AM
Dec-21-22 04:15PM
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million and $250 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in North America and Europe.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Follmann ChristianChief Operating OfficerMay 24Buy13.734556,24772,634May 25 04:18 PM
Follmann ChristianChief Operating OfficerMay 24Sale13.724556,24372,179May 25 04:18 PM
CROWELL GAYLE ADirectorMay 08Buy13.667,20098,35238,845May 09 04:17 PM
Loo WadeDirectorMar 17Buy11.954,00047,8008,059Mar 21 04:57 PM
Bluestein ScottChief Executive OfficerNov 21Sale14.16100,0001,416,000946,621Nov 22 04:38 PM